Fluzone Quadrivalent is administered by a qualified healthcare professional. Proper preparation and injection technique are crucial for its safe and effective delivery.

• Preparation: The vaccine is supplied as a prefilled syringe or multi-dose vial. Before administration, the syringe or vial should be visually inspected for particulate matter or discoloration. If any abnormalities are present, the vaccine should not be administered. The syringe or vial must be gently shaken before use.
• Administration Route: The vaccine is administered intramuscularly only. Intravenous administration is contraindicated.
• Annual Vaccination: Annual flu vaccination is strongly recommended because influenza viruses constantly evolve, and vaccine formulations are updated each year. This annual vaccination helps maintain optimal protection against the circulating strains.
• Post-Vaccination Monitoring: As with all injectable vaccines, recipients are often advised to remain at the vaccination site for 15 minutes after administration to monitor for immediate allergic reactions or vasovagal syncope (fainting).

Fluzone Quadrivalent works by stimulating the body’s immune system to produce protective antibodies against the influenza viruses it contains:

• Antigen Delivery: The vaccine contains inactive components of the four selected influenza virus strains. These components, primarily the hemagglutinin (HA) protein, are recognized by the immune system as foreign when injected.
• Immune Response Activation: The body’s immune cells, specifically B-cells and T-cells, identify these antigens. B-cells are stimulated to produce specific antibodies that can bind to and neutralize the influenza viruses if a real infection occurs. T-cells also contribute to a broader cellular immune response.
• Antibody Development: It typically takes about two weeks after vaccination for the body to develop sufficient levels of these protective antibodies.
• Protection Mechanism: If a vaccinated person is subsequently exposed to one of the influenza strains included in the vaccine, these pre-existing antibodies can rapidly respond. This rapid recognition and attack help to prevent infection or significantly reduce the severity of the illness and the risk of complications (such as pneumonia, hospitalization, and even death).

While Fluzone Quadrivalent is generally well-tolerated, like all vaccines, it can cause side effects. Most are mild and temporary. Serious side effects are rare.

• Common Local Side Effects (at injection site):
  • Pain, tenderness, redness, swelling, or a hardened lump (induration). These are usually mild to moderate and resolve within a few days.
  • Bruising.
• Common Systemic Side Effects:
  • Headache.
  • Muscle aches (myalgia).
  • Feeling unwell (malaise) or fatigue.
  • Fever or chills (more common in younger children).
  • Nausea, vomiting, diarrhea, or loss of appetite (more common in younger children).
  • Irritability, fussiness, or abnormal crying (in infants and young children).
  • Drowsiness.
• Serious Side Effects (Rare):
  • Severe Allergic Reaction (Anaphylaxis): This is rare but can occur within minutes to hours of vaccination. Symptoms include hives, swelling of the face/throat, difficulty breathing, dizziness, or weakness. Medical supervision is crucial during and immediately after vaccination to manage such reactions.
  • Guillain-Barré Syndrome (GBS): GBS is a very rare neurological disorder. While a causal link between GBS and seasonal influenza vaccines is inconclusive, if an excess risk exists, it is very small (e.g., about 1 additional case per million vaccinated persons). Individuals with a history of GBS within 6 weeks of a previous flu vaccination should discuss the risks and benefits with their doctor.
  • Syncope (Fainting): Can occur immediately after any injection, often as a psychogenic response to the needle.
  • Febrile Seizures: Seizures related to fever can occur, especially in young children prone to them.
  • Neurological disorders: Very rarely, conditions like encephalomyelitis, transverse myelitis, or brachial neuritis have been reported.

Any persistent, severe, or unusual side effects should be reported to a healthcare provider.

Several important warnings and precautions are associated with the administration of Fluzone Quadrivalent to ensure patient safety.

• Allergies: Do not administer to individuals with a history of a severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine (including egg protein, if applicable to the specific formulation) or to a previous dose of any influenza vaccine. Healthcare providers should have appropriate medical treatment readily available to manage severe allergic reactions.
• Guillain-Barré Syndrome (GBS): Individuals who have experienced GBS within 6 weeks following a previous influenza vaccination should have the decision to vaccinate based on careful consideration of potential benefits and risks with their healthcare provider.
• Altered Immunocompetence: Immunocompromised individuals, including those receiving immunosuppressive therapy, may have a lower immune response to the vaccine, potentially leading to reduced protection.
• Acute Illness: Vaccination should generally be postponed if the individual has an acute illness accompanied by a moderate or high fever. A minor illness (e.g., common cold) without fever is usually not a reason to postpone vaccination.
• Limitations of Vaccine Effectiveness: No vaccine is 100% effective. Vaccination may not protect all recipients, particularly if the circulating strains do not closely match those in the vaccine or if the individual’s immune response is suboptimal.
• Egg Allergy: According to current guidelines from public health authorities (e.g., the CDC), persons with egg allergy of any severity can generally receive any licensed, recommended influenza vaccine that is otherwise appropriate for their age and health status. However, those with a history of severe allergic reaction to egg (e.g., angioedema, respiratory distress requiring epinephrine or hospitalization) should be vaccinated in a medical setting supervised by a healthcare provider able to manage severe allergic reactions.

• Vaccines generally have limited systemic drug-drug interactions. However:
  • Immunosuppressive Therapy: In individuals with weakened immune systems (e.g., due to certain diseases or medications like high-dose corticosteroids or chemotherapy), the immune response to the vaccine might be reduced, potentially leading to less effective protection.
  • Co-administration with Other Vaccines: Fluzone Quadrivalent can generally be co-administered with other age-appropriate vaccines (e.g., COVID-19 vaccines) on the same day. However, different injection sites should be used. Always consult current immunization schedules and guidelines for co-administration.

Fluzone Quadrivalent is a prescription-only biological product (vaccine). It is administered by qualified healthcare professionals and is not available for self-administration.

• Medical Oversight: The administration of Fluzone Quadrivalent requires oversight by a licensed healthcare provider (physician, nurse, pharmacist, etc.). This ensures proper screening for contraindications, correct injection technique, and monitoring for any immediate adverse reactions.
• Not an OTC Product: Vaccines are not over-the-counter medications. Their administration is integrated into the healthcare system to ensure proper handling, cold chain management, administration by trained personnel, and comprehensive record-keeping.
• Public Health Programs: In many regions, influenza vaccination is a key component of public health initiatives, making it accessible through various channels such as doctor’s offices, clinics, pharmacies, and workplace vaccination programs.
• Record Keeping: Healthcare providers maintain detailed records of vaccination, including the vaccine type, lot number, administration date, and the identity of the person who administered it. This is vital for public health tracking, patient safety, and ensuring complete vaccination histories.
• Annual Recommendation: The recommendation for vaccination with specific influenza vaccine products is issued annually by public health authorities based on epidemiologic data and vaccine effectiveness studies for the upcoming flu season

1. What is Fluzone Quadrivalent used for? To prevent seasonal influenza in individuals aged 6 months and older.

2. What type of vaccine is it? Inactivated influenza virus vaccine (quadrivalent).

3. What strains does it protect against? Two influenza A strains (H1N1 and H3N2) and two influenza B strains (Victoria and Yamagata lineages).

4. What age group is it approved for? Ages ≥6 months.

5. What forms and strengths are available?

• 0.25 mL dose for children 6–35 months

• 0.5 mL dose for individuals ≥36 months

• Supplied in single-dose syringes and multi-dose vials.

6. Is it a live vaccine? No, it is an inactivated (non-live) vaccine.

7. What are common side effects? Injection site pain, fever, headache, muscle aches, and fatigue.

8. Can it cause serious reactions? Rarely—anaphylaxis, Guillain-Barré syndrome, or febrile seizures in young children.

9. Is it safe during pregnancy? Yes, it is recommended during pregnancy to protect both mother and baby.

10. Is a prescription required? Yes, it is administered by healthcare professionals.

11. Is it available in Pakistan? Yes, through hospitals, immunization centers, and select pharmacies.

12. Can it be used with other vaccines? Yes, it can be co-administered with other routine vaccines.

13. How long does protection last? Typically 6–12 months; annual vaccination is recommended.

14. What makes it different from trivalent flu vaccines? It includes two B strains for broader protection.

15. Is it used for COVID-19 prevention? No, it only protects against influenza.

16. Can it be used in immunocompromised patients? Yes, but under medical supervision.

17. What should be avoided after vaccination? Monitor for allergic reactions; no specific activity restrictions.

18. Is it part of routine immunization? Yes, especially during flu season.

19. What does “Quadrivalent” mean? It protects against four flu virus strains.

20. Is a booster dose needed for children? Yes—children aged 6 months to 8 years receiving flu vaccine for the first time need two doses at least 4 weeks apart.